3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$31.74
arrow_upward
+1.15%(+0.36) 1D
Oct 16, 4:08:14 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3692...
Open
HK$31.72
High
HK$32.44
Low
HK$31.52
Mkt. cap
192.48B
Avg. vol.
8.58M
Volume
10.50M
Dividend
1.53%
Quarterly dividend
HK$0.12
Ex-dividend date
Sep 22, 2026
P/E ratio
24.51
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.30
No. of employees
10K
Open
HK$31.72
High
HK$32.44
Low
HK$31.52
Mkt. cap
192.48B
Avg. vol.
8.58M
Volume
10.50M
Dividend
1.53%
Quarterly dividend
HK$0.12
Ex-dividend date
Sep 22, 2026
P/E ratio
24.51
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.30
No. of employees
10K
News stories
From web sources and news partners
Simply Wall Street
·
16 hours ago
Hansoh Pharmaceutical Group (SEHK:3692) On Pipeline Progress And Why Valuation Still Divides Views
ad-hoc-news.de
·
16 hours ago
Hansoh Pharma reports 11.71 percent revenue growth for Hansoh Pharma stock
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd